- Home
- RRBI vs AUTL Comparison
RRBI vs AUTL Comparison
Compare RRBI & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RRBI | AUTL |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 442.3M | 368.6M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RRBI | AUTL |
|---|---|---|
| Price | $72.13 | $1.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $67.00 | $8.33 |
| AVG Volume (30 Days) | 31.1K | ★ 3.9M |
| Earning Date | 01-29-2026 | 11-12-2025 |
| Dividend Yield | ★ 0.84% | N/A |
| EPS Growth | ★ 26.56 | N/A |
| EPS | ★ 6.01 | N/A |
| Revenue | ★ $118,909,000.00 | $51,128,000.00 |
| Revenue This Year | $7.10 | $658.11 |
| Revenue Next Year | N/A | $91.34 |
| P/E Ratio | $11.88 | ★ N/A |
| Revenue Growth | 11.93 | ★ 406.67 |
| 52 Week Low | $46.33 | $1.11 |
| 52 Week High | $76.13 | $3.08 |
Technical Indicators
Market Signals| Indicator | RRBI | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 63.84 | 53.89 |
| Support Level | $69.94 | $1.31 |
| Resistance Level | $72.68 | $1.66 |
| Average True Range (ATR) | 1.86 | 0.10 |
| MACD | 0.26 | 0.04 |
| Stochastic Oscillator | 90.06 | 66.30 |
Price Performance
Historical ComparisonAbout RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.